ConductScience.org, home

Paper47233

Short-course chemotherapy for pulmonary tuberculosis.

Fox W and 1 other. Am Rev Respir Dis, 1975. Cited by 169 papers, by iCite.

Cite this record

ConductScience Library. Short-course chemotherapy for pulmonary tuberculosis. Papers, record 47233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/47233

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Short-course chemotherapy for pulmonary tuberculosis.
PubMed
Journal
Am Rev Respir Dis
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
169
iCite
Relative citation ratio, by iCite
6.6
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fox WW
2Mitchison DAD A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
Tuberculosis, PulmonaryMajor topic
Africa, Eastern
Aminosalicylic Acids
Drug Resistance, Microbial
Drug Therapy, Combination
Follow-Up Studies
Isoniazid
Mycobacterium tuberculosis
Prognosis
Pyrazinamide
Recurrence
Rifampin
Sputum
Streptomycin
Thioacetazone
Time Factors

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 169 citations.

PMIDTitleJournalYearIn PapersSource
39993187Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/39993187PubMed
39649798Decoding differentially expressed genes to identify potential immunity associated biomarkers in Tuberculosis: An integrative bioinformatics approach.Biochem Biophys Rep2024https://conductscience.org/library/papers/39649798PubMed
35380903Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/35380903PubMed
32753506Distinct Bacterial Pathways Influence the Efficacy of Antibiotics against Mycobacterium tuberculosis.mSystems2020https://conductscience.org/library/papers/32753506PubMed
32106220Advances in clinical trial design: Weaving tomorrow's TB treatments.PLoS Med2020https://conductscience.org/library/papers/32106220PubMed
21201093N'-Prop-ylisonicotinohydrazide.Acta Crystallogr Sect E Struct Rep Online2008https://conductscience.org/library/papers/21201093PubMed
20894360Urological cooperatives.J R Soc Med1981https://conductscience.org/library/papers/20894360PubMed
20876380Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20876380PubMed
18747739Preventive medicine and public health: isoniazid.West J Med1976https://conductscience.org/library/papers/18747739PubMed
15353557Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.J Exp Med2004https://conductscience.org/library/papers/15353557PubMed
11216202Tuberculosis: 12. Global disease and the role of international collaboration.CMAJ2000https://conductscience.org/library/papers/11216202PubMed
8300251Short course intermittent chemotherapy in childhood tuberculosis.Infection1993https://conductscience.org/library/papers/8300251PubMed
6884240The case for short-course chemotherapy of pulmonary tuberculosis.Drugs1983https://conductscience.org/library/papers/6884240PubMed
6800550Survey of pulmonary tuberculosis in south and west Wales (1976-8).Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6800550PubMed
6749471Short-course therapy for tuberculosis.Drugs1982https://conductscience.org/library/papers/6749471PubMed
6407697Compliance of patients and physicians: experience and lessons from tuberculosis-II.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6407697PubMed
3577136Current concepts in the treatment of tuberculosis.West J Med1987https://conductscience.org/library/papers/3577136PubMed
3197749Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3197749PubMed
1182342The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.Br J Pharmacol1975https://conductscience.org/library/papers/1182342PubMed
950592Pharmacokinetics of isoniazid metabolism in man.J Pharmacokinet Biopharm1976https://conductscience.org/library/papers/950592PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/47233

GET https://conductscience.org/api/papers/v1/47233/cited_by?page=2